These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 21948088)

  • 1. Inhibition of the Notch-Hey1 axis blocks embryonal rhabdomyosarcoma tumorigenesis.
    Belyea BC; Naini S; Bentley RC; Linardic CM
    Clin Cancer Res; 2011 Dec; 17(23):7324-36. PubMed ID: 21948088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Notch-YAP Circuit Drives Stemness and Tumorigenesis in Embryonal Rhabdomyosarcoma.
    Slemmons KK; Crose LES; Riedel S; Sushnitha M; Belyea B; Linardic CM
    Mol Cancer Res; 2017 Dec; 15(12):1777-1791. PubMed ID: 28923841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyper-activation of Notch3 amplifies the proliferative potential of rhabdomyosarcoma cells.
    De Salvo M; Raimondi L; Vella S; Adesso L; Ciarapica R; Verginelli F; Pannuti A; Citti A; Boldrini R; Milano GM; Cacchione A; Ferrari A; Collini P; Rosolen A; Bisogno G; Alaggio R; Inserra A; Locatelli M; Stifani S; Screpanti I; Miele L; Locatelli F; Rota R
    PLoS One; 2014; 9(5):e96238. PubMed ID: 24797362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RBPJ is a novel target for rhabdomyosarcoma therapy.
    Nagao H; Setoguchi T; Kitamoto S; Ishidou Y; Nagano S; Yokouchi M; Abematsu M; Kawabata N; Maeda S; Yonezawa S; Komiya S
    PLoS One; 2012; 7(7):e39268. PubMed ID: 22792167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma.
    Coda DM; Lingua MF; Morena D; Foglizzo V; Bersani F; Ala U; Ponzetto C; Taulli R
    Cell Cycle; 2015; 14(9):1389-402. PubMed ID: 25644430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGFR4 blockade exerts distinct antitumorigenic effects in human embryonal versus alveolar rhabdomyosarcoma.
    Crose LE; Etheridge KT; Chen C; Belyea B; Talbot LJ; Bentley RC; Linardic CM
    Clin Cancer Res; 2012 Jul; 18(14):3780-90. PubMed ID: 22648271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human myostatin negatively regulates human myoblast growth and differentiation.
    McFarlane C; Hui GZ; Amanda WZ; Lau HY; Lokireddy S; Xiaojia G; Mouly V; Butler-Browne G; Gluckman PD; Sharma M; Kambadur R
    Am J Physiol Cell Physiol; 2011 Jul; 301(1):C195-203. PubMed ID: 21508334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of myogenesis by Notch: evidence for multiple pathways.
    Buas MF; Kabak S; Kadesch T
    J Cell Physiol; 2009 Jan; 218(1):84-93. PubMed ID: 18727102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS.
    Ciarapica R; Carcarino E; Adesso L; De Salvo M; Bracaglia G; Leoncini PP; Dall'agnese A; Verginelli F; Milano GM; Boldrini R; Inserra A; Stifani S; Screpanti I; Marquez VE; Valente S; Mai A; Puri PL; Locatelli F; Palacios D; Rota R
    BMC Cancer; 2014 Feb; 14():139. PubMed ID: 24575771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression.
    Alaña L; Sesé M; Cánovas V; Punyal Y; Fernández Y; Abasolo I; de Torres I; Ruiz C; Espinosa L; Bigas A; Y Cajal SR; Fernández PL; Serras F; Corominas M; Thomson TM; Paciucci R
    Mol Cancer; 2014 Mar; 13():74. PubMed ID: 24684754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Notch3 signalling induces rhabdomyosarcoma cell differentiation promoting p38 phosphorylation and p21(Cip1) expression and hampers tumour cell growth in vitro and in vivo.
    Raimondi L; Ciarapica R; De Salvo M; Verginelli F; Gueguen M; Martini C; De Sio L; Cortese G; Locatelli M; Dang TP; Carlesso N; Miele L; Stifani S; Limon I; Locatelli F; Rota R
    Cell Death Differ; 2012 May; 19(5):871-81. PubMed ID: 22117196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers.
    Konishi J; Kawaguchi KS; Vo H; Haruki N; Gonzalez A; Carbone DP; Dang TP
    Cancer Res; 2007 Sep; 67(17):8051-7. PubMed ID: 17804716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAML1 regulates cell viability via the NF-κB pathway in cervical cancer cell lines.
    Kuncharin Y; Sangphech N; Kueanjinda P; Bhattarakosol P; Palaga T
    Exp Cell Res; 2011 Aug; 317(13):1830-40. PubMed ID: 21640102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired Wnt signaling in embryonal rhabdomyosarcoma cells from p53/c-fos double mutant mice.
    Singh S; Vinson C; Gurley CM; Nolen GT; Beggs ML; Nagarajan R; Wagner EF; Parham DM; Peterson CA
    Am J Pathol; 2010 Oct; 177(4):2055-66. PubMed ID: 20829439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma.
    Taulli R; Scuoppo C; Bersani F; Accornero P; Forni PE; Miretti S; Grinza A; Allegra P; Schmitt-Ney M; Crepaldi T; Ponzetto C
    Cancer Res; 2006 May; 66(9):4742-9. PubMed ID: 16651427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical rationale for entinostat in embryonal rhabdomyosarcoma.
    Bharathy N; Berlow NE; Wang E; Abraham J; Settelmeyer TP; Hooper JE; Svalina MN; Bajwa Z; Goros MW; Hernandez BS; Wolff JE; Pal R; Davies AM; Ashok A; Bushby D; Mancini M; Noakes C; Goodwin NC; Ordentlich P; Keck J; Hawkins DS; Rudzinski ER; Mansoor A; Perkins TJ; Vakoc CR; Michalek JE; Keller C
    Skelet Muscle; 2019 May; 9(1):12. PubMed ID: 31113472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Notch pathway prevents osteosarcoma growth by cell cycle regulation.
    Tanaka M; Setoguchi T; Hirotsu M; Gao H; Sasaki H; Matsunoshita Y; Komiya S
    Br J Cancer; 2009 Jun; 100(12):1957-65. PubMed ID: 19455146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hippo transducer YAP1 transforms activated satellite cells and is a potent effector of embryonal rhabdomyosarcoma formation.
    Tremblay AM; Missiaglia E; Galli GG; Hettmer S; Urcia R; Carrara M; Judson RN; Thway K; Nadal G; Selfe JL; Murray G; Calogero RA; De Bari C; Zammit PS; Delorenzi M; Wagers AJ; Shipley J; Wackerhage H; Camargo FD
    Cancer Cell; 2014 Aug; 26(2):273-87. PubMed ID: 25087979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation.
    Megiorni F; Camero S; Ceccarelli S; McDowell HP; Mannarino O; Marampon F; Pizer B; Shukla R; Pizzuti A; Marchese C; Clerico A; Dominici C
    Oncotarget; 2016 Nov; 7(48):79342-79356. PubMed ID: 27764816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 12-O-tetradecanoylphorbol-13-acetate and EZH2 inhibition: A novel approach for promoting myogenic differentiation in embryonal rhabdomyosarcoma cells.
    Marchesi I; Sanna L; Fais M; Fiorentino FP; Giordano A; Bagella L
    J Cell Physiol; 2018 Mar; 233(3):2360-2365. PubMed ID: 28722764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.